Anondita Medicare Secures ₹2.92 Crore Government Supply Order; Shares Rise 2%

Mumbai, June 17: Anondita Medicare Ltd has received a purchase order worth ₹2.92 crore from the Central Medical Services Society (CMSS), an autonomous procurement agency under the Ministry of Health and Family Welfare, Government of India, according to an exchange filing.

The order relates to the supply of Condoms SMO (Ustad Nirodh-HLL) [363] and carries a total value of ₹2,92,41,000.

While the order size may appear modest compared with large industrial contracts, it is significant for a specialised healthcare products company such as Anondita Medicare. Government procurement contracts typically provide assured demand, timely execution visibility and strengthen a supplier’s credentials for future tenders.

According to the filing, the order will be executed in two phases. Half of the quantity is scheduled to be supplied within 60 days from the date of the purchase order, while the balance is to be delivered between 61 and 120 days.

The company clarified that the contract has been awarded by a domestic government entity and does not involve any promoter or related-party interest.

Stock Market Snapshot

Anondita Medicare share price moved higher in morning trade following the disclosure of the government order.

As of 9:42 AM IST on June 17, 2026, shares of Anondita Medicare Ltd were trading at ₹1,225.00, up ₹28.05 or 2.34% from the previous close.

The stock remained firmly in positive territory during the opening session as investors assessed the impact of the fresh order on the company’s near-term business outlook.

The Anondita Medicare share price has attracted attention in recent months amid growing investor interest in healthcare manufacturing companies benefiting from government procurement opportunities and public health programmes.

Government Orders Remain Important for Healthcare Suppliers

The CMSS acts as a key procurement agency for various healthcare products and medical supplies used in public health initiatives across the country.

For companies operating in the healthcare and medical consumables segment, securing repeat government orders can help improve revenue visibility and strengthen relationships with institutional buyers.

Such contracts also provide validation of manufacturing capabilities and compliance standards, factors that are often important when competing for future tenders.

The latest order further expands Anondita Medicare’s participation in government-backed healthcare supply programmes and reinforces its presence in the medical consumables segment.

Company Background

Anondita Medicare is engaged in the healthcare products and medical consumables business, supplying products across institutional and commercial channels.

The company serves both government and private-sector customers and participates in tender-based procurement programmes for healthcare-related products.

Government contracts remain an important component of its business mix, providing recurring opportunities across public health initiatives.

Conclusion

The ₹2.92 crore CMSS order may not be transformational in size, but it adds to Anondita Medicare’s government order book and offers near-term execution visibility.

Investor reaction remained positive, with the stock gaining more than 2% in early trade as the market welcomed another government contract from a key healthcare procurement agency.

Source:

• https://www.nseindia.com/get-quote/equity/ANONDITA/Anondita-Medicare-Limited
• https://nsearchives.nseindia.com/corporate/ANONDITA_16062026205014_AML_Intimation_of_Bagging__of_Order_CMSS.pdf